QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)
Clinical trial NCT02465957 · TERMINATED
Trial details
- NCT number
- NCT02465957
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-24
- Primary completion
- 2018-03-19
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.